Navigation Links
Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent

Abbott's everolimus-eluting bioabsorbable stent is made of polylactic acid, a proven biocompatible material that is commonly used in medical implants such as dissolvable sutures. As with a metallic stent, the bioabsorbable stent is designed to restore blood flow by propping the vessel open, providing support until the blood vessel heals. Unlike a metallic stent, a bioabsorbable stent is designed to be slowly metabolized by the body and completely absorbed over time.

"Based on these encouraging safety results, Abbott will continue to advance this technology by enrolling the next cohort of patients in the ABSORB study in Europe and New Zealand," said John M. Capek, Ph.D., senior vice president, Abbott Vascular. "The next phase of the ABSORB study will utilize a next-generation bioabsorbable everolimus-eluting stent that incorporates several advancements designed to improve strength and deliverability."

About the ABSORB Trial

The ABSORB trial is a prospective, non-randomized (open label) study designed to enroll up to 60 patients in Belgium, Denmark, France, New Zealand, Poland and The Netherlands. Key endpoints of the study include assessments of safety -- MACE and stent thrombosis (blood clot formation) rates -- at 30, 180 and 270 days, with an annual follow-up for up to five years, and successful deployment of the bioabsorbable drug-eluting stent. Other key endpoints of the study include follow-up measurements assessed by angiography, IVUS, and state- of-the-art imaging modalities at 180 days and two years, as well as a new noninvasive technique in a subset of patients at 18 months. The co-principal investigator of the study is John Ormiston, M.D., of Mercy Hospital in Auckland, New Zealand.

For images of Abbott's bioabsorbable stent and other information, please visit the company's online ACC newsroom at http://www.abbottvascular.com/ACCpresskit .

About Abbot
'"/>




Page: 1 2 3

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
9. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:7/1/2015)... , July 1, 2015  Genoa has acquired West ... ), adding another pharmacy location with a proven track ... and in residential settings, and those involved in their ... service, flexibility and delivering true value to their customers. ... the leading provider of pharmacy services dedicated to the ...
(Date:7/1/2015)... , July 1, 2015 Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... Bob Radie , president and chief executive officer, ... summer. He will provide an update on Egalet,s ... tromethamine) Nasal Spray, approved product OXAYDO ™ ...
(Date:7/1/2015)... SAN FRANCISCO , July 1, 2015 ... health market) is expected to reach USD 49,119.2 million ... View Research, Inc. Monitoring services is expected to remain ... revenue of USD 1,227.5 million in 2012, and an ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ...
Breaking Medicine Technology:Genoa, a QoL Healthcare Company Acquires West Bend Assisted Living Pharmacy 2Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5
... 2011 Scientists at Osel Inc . and ... a new way to prevent HIV infection by genetically ... block viral transmission. Bioengineered bacteria introduced into the vaginal ... of simian HIV (SHIV) by nearly two thirds. ...
... July 18, 2011 Data from high-risk patients requiring ... nondeferrable, non-cardiac surgery show good short- and long-term clinical ... according to a study published online on the journal ... In the single-center study, patients treated with the Genous ...
Cached Medicine Technology:Scientists Use Live Bacteria to Fight HIV 2Scientists Use Live Bacteria to Fight HIV 3OrbusNeich's Genous™ Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery 2OrbusNeich's Genous™ Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery 3
(Date:7/1/2015)... WA (PRWEB) , ... July 01, 2015 , ... ... war in this land of liberty. Americans have been arguing over laws governing ... a particularly contentious period, as a forthcoming historical comparative biography by Cindy Safronoff ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... long term care, specialty, combo, and compounding pharmacy operations, announces the most recent ... the Cardinal Health RBC event at the Venetian Las Vegas, Nevada. ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... as organically raised chickens and eggs. Eating organic foods and products can help ... and more environmentally friendly than production chicken farming. Choosing home raised chickens and ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Dr. Surya ... Monday, July 6th on WAVY-TV’s The Hampton Roads Show to discuss non-invasive CoolSculpting ... diet and exercise fall short. , CoolSculpting fat reduction utilizes Cryolipolysis to literally ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Renowned rhinoplasty ... dates for the 2016 Dallas Rhinoplasty Symposium . Set for March 6th - ... Designed to take participants from the basic training and fundamentals of nasal surgery through ...
Breaking Medicine News(10 mins):Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3
... Continued Strong ... Growth Full-Year 2007 ... pre-split compared to 2006, excluding the 2006 legal settlements charge, and ... 2006 legal settlements charge (see Table ...
... Hospital, located in,Columbus, Ind., has selected TransUnion,s Healthcare ... typically resulting from medical bills sent,to wrong addresses., ... in our emergency room and when,those individuals are ... the right,state of mind to provide their correct ...
... in ... -, NEW HAVEN, Conn. and KORTRIJK, Belgium, Feb. ... company,focused on bringing proprietary medicines to the China market, ... RHEI has,licensed from MethaPharma the exclusive right to market ...
... 18 ARMSRx (Administered Risk,Management Services Rx), ... in transparent pharmacy benefits negotiation and,assessment, has ... The New Jersey,Hospital Association,s (NJHA) Employee Benefit ... hospitals, third party,administrators and employers participating in ...
... when people were encouraged to use them , , MONDAY, ... access to their surgeon appears to improve communication, a ... would like to have e-mail access to their physicians," ... February issue of the Archives of Surgery . ...
... Spanish-language television is bombarding children with so many fast-food ... epidemic among Latino youth, according to research led by ... who make up one-fifth of the U.S. child population, ... all ethnic groups. , A report on the ...
Cached Medicine News:Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 2Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 3Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 4Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 5Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 6Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 7Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 8Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 9Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 10Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 11Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 12Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 13Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 14Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 15Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 16Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 17Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 18Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 19Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 20Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 21Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 22Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 23Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 24Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 25Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 26Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 27Health News:Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations 28Health News:Columbus Regional Hospital Selects TransUnion's Healthcare Revenue Cycle Platform to Improve Its Emergency Department's Registration Process and Reduce Bad Debt 2Health News:Columbus Regional Hospital Selects TransUnion's Healthcare Revenue Cycle Platform to Improve Its Emergency Department's Registration Process and Reduce Bad Debt 3Health News:RHEI Pharmaceuticals Licenses Attental From MethaPharma (Vemedia Group) for Distribution Throughout Asia 2Health News:RHEI Pharmaceuticals Licenses Attental From MethaPharma (Vemedia Group) for Distribution Throughout Asia 3Health News:New Jersey Hospital Association Prescription Program Outpaces Industry 2Health News:E-mails Improve Patient-Surgeon Communication 2Health News:Child obesity seen as fueled by Spanish language tv ads 2
Cottle Tenaculum Skin Hook. 5 1/2" small, shallow curve....
Large....
Gillies (Converse) Skin Hook, small hook size....
3 mm electrode Inserts - monopolar foot control connection....
Medicine Products: